Minor
AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Dec 2026 to Oct 9, 2026
AeroRx Therapeutics Inc.Phase 1 NCT07802730 Registry history of NCT07802730 on ClinicalTrials.gov (opens the registry)